Evidence map›Paper›PMID 34273166›Full record

ArticleCardiovascular research2022

Nicotine promotes vascular calcification via intracellular Ca2+-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells.

Ploingarm Petsophonsakul, Mathias Burgmaier, Brecht Willems, Sylvia Heeneman, Nadina Stadler, Felix Gremse, Sebastian Reith, Kathrin Burgmaier, Florian Kahles, Nikolaus Marx and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Curcumin mitigated aflatoxin BJournal of animal science and biotechnology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Low dose thirdhand smoke exposure enhances platelet functional responses in mice.Experimental biology and medicine (Maywood, N.J.) · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Ploingarm PetsophonsakulDepartment of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-0811-9992
Mathias BurgmaierDepartment of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Brecht WillemsDepartment of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Sylvia HeenemanDepartment of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Nadina StadlerDepartment of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-3064-9180
Felix GremseExperimental Molecular Imaging, University Hospital of the RWTH Aachen, Aachen, Germany.
Sebastian ReithDepartment of Cardiology, St. Franziskus Hospital Münster, Münster, Germany.
Kathrin BurgmaierDepartment of Pediatrics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.ORCID 0000-0001-9787-1096
Florian KahlesDepartment of Cardiology, Medical Clinic I, University Hospital of the RWTH Aachen, Aachen, Germany.
Nikolaus MarxDepartment of Cardiology, Medical Clinic I, University Hospital of the RWTH Aachen, Aachen, Germany.ORCID 0000-0001-6141-634X
Ehsan NatourDepartment of Cardiovascular Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.
Elham BidarDepartment of Cardiovascular Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.
Michael JacobsDepartment of Vascular Surgery, European Vascular Center Aachen-Maastricht, Maastricht, The Netherlands.
Barend MeesDepartment of Vascular Surgery, European Vascular Center Aachen-Maastricht, Maastricht, The Netherlands.ORCID 0000-0001-6545-5813
Chris ReutelingspergerDepartment of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-2334-9403
Malgorzata FurmanikDepartment of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-3583-9784
Leon SchurgersDepartment of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-7867-6957
Maastricht University · NLRWTH Aachen University · DESt. Franziskus Hospital · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsSmokers are at increased risk of cardiovascular events. However, the exact mechanisms through which smoking influences cardiovascular disease resulting in accelerated atherosclerosis and vascular calcification are unknown. The aim of this study was to investigate effects of nicotine on initiation of vascular smooth muscle cell (VSMC) calcification and to elucidate underlying mechanisms. METHODS AND

resultsWe assessed vascular calcification of 62 carotid lesions of both smoking and non-smoking patients using ex vivo micro-computed tomography (µCT) scanning. Calcification was present more often in carotid plaques of smokers (n = 22 of 30, 73.3%) compared to non-smokers (n = 11 of 32, 34.3%; P < 0.001), confirming higher atherosclerotic burden. The difference was particularly profound for microcalcifications, which was 17-fold higher in smokers compared to non-smokers. In vitro, nicotine-induced human primary VSMC calcification, and increased osteogenic gene expression (Runx2, Osx, BSP, and OPN) and extracellular vesicle (EV) secretion. The pro-calcifying effects of nicotine were mediated by Ca2+-dependent Nox5. SiRNA knock-down of Nox5 inhibited nicotine-induced EV release and calcification. Moreover, pre-treatment of hVSMCs with vitamin K2 ameliorated nicotine-induced intracellular oxidative stress, EV secretion, and calcification. Using nicotinic acetylcholine receptor (nAChR) blockers α-bungarotoxin and hexamethonium bromide, we found that the effects of nicotine on intracellular Ca2+ and oxidative stress were mediated by α7 and α3 nAChR. Finally, we showed that Nox5 expression was higher in carotid arteries of smokers and correlated with calcification levels in these vessels.

conclusionIn this study, we provide evidence that nicotine induces Nox5-mediated pro-calcific processes as novel mechanism of increased atherosclerotic calcification. We identified that activation of α7 and α3 nAChR by nicotine increases intracellular Ca2+ and initiates calcification of hVSMCs through increased Nox5 activity, leading to oxidative stress-mediated EV release. Identifying the role of Nox5-induced oxidative stress opens novel avenues for diagnosis and treatment of smoking-induced cardiovascular disease.

Indexed as

AtherosclerosisCardiovascular DiseasesExtracellular VesiclesMuscle, Smooth, VascularNicotineVascular CalcificationCalciumCells, CulturedHumansMyocytes, Smooth MuscleNADPH Oxidase 5Oxidative StressX-Ray MicrotomographyCalciumNADPH Oxidase 5NicotineNOX5 protein, humanNicotine Vascular calcification Vascular smooth muscle cell phenotypic switching Nox5 Vitamin K2

Identifiers

PMID34273166
PMCPMC9302892
OpenAlexW3184002982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.